BioNTech SE (BNTX) Other Operating Expenses (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Other Operating Expenses data on file, last reported at $40.0 million in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses changed 0.34% year-over-year to $40.0 million; the trailing twelve-month figure through Dec 2025 stood at $222.9 million (up 40.47% YoY), and the FY2025 full-year result was $208.6 million, up 38.82% from the prior year.
• Other Operating Expenses advanced to $40.0 million in Q4 2025, from $29.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $603.7 million in Q2 2022 to a low of $4.3 million in Q4 2023.
• A 5-year average of $132.3 million and a median of $61.6 million in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 94870122.6% in 2021 and tumbled 98.1% in 2023, its largest moves.
• Tracing BNTX's Other Operating Expenses over 5 years: stood at $272.0 million in 2021, then dropped by 16.89% to $226.1 million in 2022, then plunged by 98.1% to $4.3 million in 2023, then surged by 833.58% to $40.2 million in 2024, then decreased by 0.34% to $40.0 million in 2025.
• Business Quant data shows BNTX's Other Operating Expenses at $40.0 million in Q4 2025, $29.6 million in Q3 2025, and $88.5 million in Q2 2025.